LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 69

Search options

  1. Article ; Online: A study of the 20-year evolution of antimicrobial resistance patterns of pediatric urinary tract infections in a single center.

    Dejonckheere, Yasmina / Desmet, Stefanie / Knops, Noël

    European journal of pediatrics

    2022  Volume 181, Issue 9, Page(s) 3271–3281

    Abstract: Febrile urinary tract infections (UTIs) are important bacterial infections in children but increasingly difficult to treat due to antimicrobial resistance. We performed a retrospective analysis of the prevalence of uropathogens in hospitalized children ... ...

    Abstract Febrile urinary tract infections (UTIs) are important bacterial infections in children but increasingly difficult to treat due to antimicrobial resistance. We performed a retrospective analysis of the prevalence of uropathogens in hospitalized children with a febrile UTI between 2000 and 2019 in our university hospital to get more insight into trend and determinants of antimicrobial resistance over time. There were 1010 hospitalizations in children with a median age of 1.1 years. Thirty-six percent had an abnormal ultrasound and/or the presence of vesico-ureteral reflux, defined as CAKUT. Escherichia coli was the most prevalent pathogen (76%). However, there was an increasing prevalence towards other gram-negative organisms over time, and these pathogens were more common in children with congenital anomalies of kidney and urinary tract (CAKUT) (OR 4.26 (3.14-5.78), p < 0.001). E. coli strains demonstrated an increase in resistance against amoxicillin clavulanic acid (AMC) over time from 16% (2000-2004) to 36% (2015-2019) with an average increase of 2.0%/year; this was + 1.1%/year for third-generation cephalosporin. Multivariate analysis demonstrated that prior antibiotic use was an additional risk factor for antimicrobial resistance in E. coli. Nevertheless, increasing resistance was also observed in children without reported previous antibiotic treatment (+ 1.9%/year, p = 0.04).    Conclusion: We observed a significant pattern of increasing antimicrobial resistance of E. coli within a relatively short period of time, making it increasingly difficult to treat pediatric UTIs. This pattern was also seen in children without underlying risk factors (recent antibiotic treatment or structural urological disease). This is indicative for a larger problem in the general population and an important threat to our current standard of health care. What is Known: • Escherichia coli is the most frequent pathogen in pediatric urinary tract infections. • There is an increasing antimicrobial resistance against commonly used antibiotics in urinary tract infections. What is New: • The first 20-year retrospective, longitudinal study on characteristics of the microorganisms of pediatric urinary tract infections in a single center. • A 1-2% yearly increase in antimicrobial resistance, not only in children with congenital anomalies of the kidneys or recent antibiotic treatment but also in children without risk factors.
    MeSH term(s) Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Child ; Drug Resistance, Bacterial ; Escherichia coli ; Escherichia coli Infections/drug therapy ; Escherichia coli Infections/epidemiology ; Humans ; Infant ; Longitudinal Studies ; Microbial Sensitivity Tests ; Retrospective Studies ; Urinary Tract Infections/drug therapy ; Urinary Tract Infections/epidemiology ; Urinary Tract Infections/etiology ; Urogenital Abnormalities ; Vesico-Ureteral Reflux
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2022-06-23
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 194196-3
    ISSN 1432-1076 ; 0340-6199 ; 0943-9676
    ISSN (online) 1432-1076
    ISSN 0340-6199 ; 0943-9676
    DOI 10.1007/s00431-022-04538-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Infant Pneumococcal Carriage in Belgium Not Affected by COVID-19 Containment Measures.

    Willen, Laura / Ekinci, Esra / Cuypers, Lize / Theeten, Heidi / Desmet, Stefanie

    Frontiers in cellular and infection microbiology

    2022  Volume 11, Page(s) 825427

    Abstract: Streptococcus ... ...

    Abstract Streptococcus pneumoniae
    MeSH term(s) Aged ; Belgium ; COVID-19 ; Carrier State/epidemiology ; Child ; Child, Preschool ; Humans ; Infant ; Nasopharynx ; Pandemics ; Pneumococcal Infections/epidemiology ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines ; SARS-CoV-2 ; Streptococcus pneumoniae
    Chemical Substances Pneumococcal Vaccines
    Language English
    Publishing date 2022-01-17
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2619676-1
    ISSN 2235-2988 ; 2235-2988
    ISSN (online) 2235-2988
    ISSN 2235-2988
    DOI 10.3389/fcimb.2021.825427
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Underlying factors in paediatric invasive pneumococcal disease in Belgium - Authors' reply.

    Desmet, Stefanie / Lagrou, Katrien / Peetermans, Willy E / Blumental, Sophie

    The Lancet. Infectious diseases

    2021  Volume 21, Issue 2, Page(s) 170

    MeSH term(s) Belgium/epidemiology ; Child ; Humans ; Pneumococcal Infections/epidemiology ; Pneumococcal Infections/prevention & control ; Pneumococcal Vaccines ; Retrospective Studies ; Vaccines, Conjugate
    Chemical Substances Pneumococcal Vaccines ; Vaccines, Conjugate
    Language English
    Publishing date 2021-01-30
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/S1473-3099(20)30940-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The 20-valent pneumococcal conjugate vaccine (PCV20): expected added value.

    Janssens, Esther / Flamaing, Johan / Vandermeulen, Corinne / Peetermans, Willy E / Desmet, Stefanie / De Munter, Paul

    Acta clinica Belgica

    2022  , Page(s) 1–9

    Abstract: Objectives: Currently existing pneumococcal vaccines have contributed to a major reduction in pneumococcal disease. However, there remains an unmet need for vaccine coverage of serotypes not included in PCV13 to further reduce the burden of disease. The ...

    Abstract Objectives: Currently existing pneumococcal vaccines have contributed to a major reduction in pneumococcal disease. However, there remains an unmet need for vaccine coverage of serotypes not included in PCV13 to further reduce the burden of disease. The objective of this review is to assess the potential impact of implementation of the investigational 20-valent pneumococcal conjugate vaccine (PCV20) in the childhood and adult immunization programme in Belgium and Europe.
    Methods: A literature search was conducted to identify publications and surveillance reports concerning the effectiveness and safety of pneumococcal vaccines, epidemiological data on pneumococcal disease or serotype distribution dynamics after introduction of systematic vaccination.
    Results: Serotypes included in PCV20 currently account for the majority of pneumococcal disease in Belgium and Europe. In Belgium, PCV20-serotypes accounted for 71.4% of invasive pneumococcal disease (IPD) cases across all age groups in 2019, of which 39.2% were caused by PCV20-non-PCV13-serotypes. In Europe, these seven serotypes accounted for 37,6% of IPD cases in 2018.  PCV20 has proven to be well tolerated in vaccine-naïve adults and elicits a substantial immune response against all serotypes included.
    Conclusion: Due to serotype replacement following the introduction of PCV7 and PCV13, a considerable proportion of pneumococcal disease is currently caused by PCV20-serotypes. PCV20 has the potential of preventing more pneumococcal disease in children and the adult population at risk than the existing conjugate vaccines. The available evidence on safety and immunogenicity of PCV20 is promising, but further research is needed to provide data about vaccine effectiveness, immune response duration and replacement phenomenon after introduction of PCV20.
    Language English
    Publishing date 2022-02-16
    Publishing country England
    Document type Journal Article
    ZDB-ID 390201-8
    ISSN 2295-3337 ; 0001-5512 ; 1784-3286
    ISSN (online) 2295-3337
    ISSN 0001-5512 ; 1784-3286
    DOI 10.1080/17843286.2022.2039865
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Corrigendum to "In search of viable SARS-CoV-2 in the tear film: a prospective clinical study in hospitalized symptomatic patients" [Clin Microbiol Infect 28(8) (2022 Aug) 1172-1173].

    Leysen, Laura / Delbeke, Heleen / Desmet, Stefanie / Schauwvlieghe, Pieter-Paul / Maes, Piet / Blanckaert, Gauthier / Matthys, Emiel / Joossens, Marie / Casteels, Ingele

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

    2023  Volume 29, Issue 9, Page(s) 1217

    Language English
    Publishing date 2023-05-09
    Publishing country England
    Document type Published Erratum
    ZDB-ID 1328418-6
    ISSN 1469-0691 ; 1470-9465 ; 1198-743X
    ISSN (online) 1469-0691
    ISSN 1470-9465 ; 1198-743X
    DOI 10.1016/j.cmi.2023.05.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A first case of

    Van Hees, Stijn / Desmet, Stefanie / VanOverbeke, Lode / Mertens, Geertrui / Verbeke, Len / Goegebuer, Truus / Lemmens, Ann

    Acta clinica Belgica

    2023  Volume 78, Issue 6, Page(s) 521–523

    Abstract: We present a case of a 80-year-old patient with a catheter-related bloodstream infection caused by Chimaeribacter species. The Chimaeribacter genus represents a novel genus within the Yersiniaceae family. To the best of our knowledge, as of today, ... ...

    Abstract We present a case of a 80-year-old patient with a catheter-related bloodstream infection caused by Chimaeribacter species. The Chimaeribacter genus represents a novel genus within the Yersiniaceae family. To the best of our knowledge, as of today, nothing is known about the pathogenicity of Chimaeribacter species, nor about the appropriate antimicrobial management. In the present case, we demonstrate, for the first time, a potential clinical relevance of the Chimaeribacter species. Antimicrobial susceptibility data are presented.
    Language English
    Publishing date 2023-08-17
    Publishing country England
    Document type Journal Article
    ZDB-ID 390201-8
    ISSN 2295-3337 ; 0001-5512 ; 1784-3286
    ISSN (online) 2295-3337
    ISSN 0001-5512 ; 1784-3286
    DOI 10.1080/17843286.2023.2246227
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: No in vitro activity of cefiderocol against OXA-427-producing Enterobacterales.

    Jacob, Ann-Sophie / Chong, Ga-Lai / Lagrou, Katrien / Depypere, Melissa / Desmet, Stefanie

    The Journal of antimicrobial chemotherapy

    2021  Volume 76, Issue 12, Page(s) 3317–3318

    MeSH term(s) Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Cephalosporins ; Microbial Sensitivity Tests ; beta-Lactamases/genetics ; Cefiderocol
    Chemical Substances Anti-Bacterial Agents ; Cephalosporins ; beta-Lactamases (EC 3.5.2.6)
    Language English
    Publishing date 2021-08-24
    Publishing country England
    Document type Letter
    ZDB-ID 191709-2
    ISSN 1460-2091 ; 0305-7453
    ISSN (online) 1460-2091
    ISSN 0305-7453
    DOI 10.1093/jac/dkab304
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Switch in childhood pneumococcal vaccine in Belgium.

    Desmet, Stefanie / Peetermans, Willy / Lagrou, Katrien

    The Lancet. Infectious diseases

    2018  Volume 18, Issue 9, Page(s) 945–946

    MeSH term(s) Belgium ; Pneumococcal Vaccines ; Streptococcus pneumoniae/immunology ; Vaccination
    Chemical Substances 10-valent pneumococcal conjugate vaccine ; Pneumococcal Vaccines
    Language English
    Publishing date 2018-08-27
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 2061641-7
    ISSN 1474-4457 ; 1473-3099
    ISSN (online) 1474-4457
    ISSN 1473-3099
    DOI 10.1016/S1473-3099(18)30484-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Ways to Improve Insights into Clindamycin Pharmacology and Pharmacokinetics Tailored to Practice.

    Armengol Álvarez, Laura / Van de Sijpe, Greet / Desmet, Stefanie / Metsemakers, Willem-Jan / Spriet, Isabel / Allegaert, Karel / Rozenski, Jef

    Antibiotics (Basel, Switzerland)

    2022  Volume 11, Issue 5

    Abstract: Given the increase in bacterial resistance and the decrease in the development of new antibiotics, the appropriate use of old antimicrobials has become even more compulsory. Clindamycin is a lincosamide antibiotic approved for adults and children as a ... ...

    Abstract Given the increase in bacterial resistance and the decrease in the development of new antibiotics, the appropriate use of old antimicrobials has become even more compulsory. Clindamycin is a lincosamide antibiotic approved for adults and children as a drug of choice for systemic treatment of staphylococcal, streptococcal, and gram-positive anaerobic bacterial infections. Because of its profile and high bioavailability, it is commonly used as part of an oral multimodal alternative for prolonged parenteral antibiotic regimens, e.g., to treat bone and joint or prosthesis-related infections. Clindamycin is also frequently used for (surgical) prophylaxis in the event of beta-lactam allergy. Special populations (pediatrics, pregnant women) have altered cytochrome P450 (CYP)3A4 activity. As clindamycin is metabolized by the CYP3A4/5 enzymes to bioactive N-demethyl and sulfoxide metabolites, knowledge of the potential relevance of the drug's metabolites and disposition in special populations is of interest. Furthermore, drug-drug interactions derived from CYP3A4 inducers and inhibitors, and the data on the impact of the disease state on the CYP system, are still limited. This narrative review provides a detailed survey of the currently available literature on pharmacology and pharmacokinetics and identifies knowledge gaps (special patient population, drug-drug, and drug-disease interactions) to describe a research strategy for precision medicine.
    Language English
    Publishing date 2022-05-21
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2681345-2
    ISSN 2079-6382
    ISSN 2079-6382
    DOI 10.3390/antibiotics11050701
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: In search of viable SARS-CoV-2 in the tear film: a prospective clinical study in hospitalized symptomatic patients.

    Leysen, Laura / Delbeke, Heleen / Desmet, Stefanie / Schauwvlieghe, Pieter-Paul / Maes, Piet / Blanckaert, Gauthier / Matthys, Emiel / Joossens, Marie / Casteels, Ingele

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

    2022  Volume 28, Issue 8, Page(s) 1172–1173

    MeSH term(s) COVID-19/diagnosis ; Humans ; Prospective Studies ; SARS-CoV-2/isolation & purification ; Tears/virology
    Language English
    Publishing date 2022-03-31
    Publishing country England
    Document type Letter
    ZDB-ID 1328418-6
    ISSN 1469-0691 ; 1470-9465 ; 1198-743X
    ISSN (online) 1469-0691
    ISSN 1470-9465 ; 1198-743X
    DOI 10.1016/j.cmi.2022.03.026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top